
The European Medicines Agency (EMA) on Thursday backed the use of Novavax's COVID-19 shot as a booster for adults, ahead of an anticipated rise in infections this winter.
The vaccine, Nuvaxovid, is designed to target the strain of the virus that originally emerged in China. The EMA's recommendation is for people who previously were inoculated with either the Novavax shot, or any other COVID vaccine.